Cycle 2 – Module 7 – Lecture 7 – Stroke: Hormone Therapies to prevent or decrease damage of stroke (2h52)

Abstract:

This instructive video lecture offers new insights and solutions in the treatment of stroke by correcting hormone deficiencies with hormone supplements. In acute cases, these treatments help to reduce the damage and might emerge as essential adjuvants in the treatment of acute stroke.

Melatonin can safely be applied at high doses to reduce substantially the damage both in ischemic as in hemorrhagic stroke. Most other treatments that help in cases of ischemic stroke, such as testosterone, GH (growth hormone), IGF-1, transdermal estradiol, progesterone, and DHEA may also reduce damage of hemorrhagic stroke thanks to their anabolic effects and antioxidant, and for many hormones blood fluidifying and anti-atherosclerotic effects.

The observational studies and randomized controlled trials that demonstrate these stroke-preventive and stroke-reducing effects are discussed in this session together with the scientific data and practical tips.

To treat acute hemorrhagic stroke, vasopressin is usually indicated and efficient. Thyroid therapy is useful to prevent hemorrhagic stroke by increasing the production of coagulation factors and opposing development of atherosclerosis. In acute stroke, its beneficial effects may not be as important.

More information is included in this session that makes this session attractive and informative with relevant pictures and scientific references

Content is one video of 2h52, a PDF presentation file, a PDF references on:

| The 6 major hormone therapies that may prevent or reduce ischemic stroke

• Testosterone
• Melatonin
• GH (growth hormone)
• IGF-1
• Transdermal estradiol
• Progesterone

| Other hormone therapies that may prevent or reduce ischemic stroke: DHEA, thyroid

| The 2 major hormone therapies that may prevent or reduce hemorrhagic stroke

• Vasopressin
• Thyroid (preventively, not acutely)

 

| The 6 major hormone therapies that may limit the damage of hemorrhagic stroke

• Melatonin
• Testosterone
• GH (growth hormone)
• IGF-1
• Transdermal estradiol
• Progesterone

 

| Rich in scientific studies

| Many pictures

| Practical tips, doses

 

Educational outcome:

Transmission of knowledge helping to know which hormone deficiencies may facilitate or even cause stroke, and how hormone supplementations may reduce these disorders.

 

Learning outcomes:

• The physician should have learned to detect the hormone deficit(s) that cause or increase the risk of stroke in patients.
• The physician should have learned to differentiate clinically (symptomatically) which hormone deficiency is behind stroke by recognizing other signs of symptoms of the causative hormone deficiency and by laboratory tests.
• The physician should have learned more about how to treat a hormone deficiency and even be able to finetune the doses to the needs and degree of stroke of his or her patient.
• The physician should get to know the scientific studies that support this information, including double-blind placebo-controlled trials.